Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Jenning V and Gohla SH Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul pmid:11253932
pmid:
Chi N et al. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer. Pharm Dev Technol pmid:19671037
Perez MA et al. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix. 1993 P R Health Sci J pmid:8140204
zur Mühlen A et al. Atomic force microscopy studies of solid lipid nanoparticles. 1996 Pharm. Res. pmid:8893284
Iloañusi NO and Schwartz JB The effect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization. 1998 Drug Dev Ind Pharm pmid:15605595
Barthelemy P et al. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. 1999 Eur J Pharm Biopharm pmid:10234531
Freitas C and Müller RH Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. 1999 Jan-Feb J Microencapsul pmid:9972503
Schöler N et al. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. 2000 Int J Pharm pmid:10699726
Jenning V et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. 2000 Eur J Pharm Biopharm pmid:10799811
Faham A et al. Hot melt coating technology: influence of Compritol 888 Ato and granule size on chloroquine release. 2000 Pharmazie pmid:10907253
Mirghani A et al. Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. 2000 Drug Dev Ind Pharm pmid:10872101
Faham A et al. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. 2000 Drug Dev Ind Pharm pmid:10697753
Obaidat AA and Obaidat RM Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. 2001 Eur J Pharm Biopharm pmid:11522491
Hamdani J et al. Development and evaluation of prolonged release pellets obtained by the melt pelletization process. 2002 Int J Pharm pmid:12270253
N'Diaye A et al. Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. 2003 Int J Pharm pmid:12623202
Hamdani J et al. Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. 2003 Int J Pharm pmid:12818809
Zhang YE and Schwartz JB Melt granulation and heat treatment for wax matrix-controlled drug release. 2003 Drug Dev Ind Pharm pmid:12648009
Jannin V et al. Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating. 2003 Int J Pharm pmid:12927386
Gu X et al. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. 2004 Drug Dev Ind Pharm pmid:15595567
Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate. 2004 Int. J. Toxicol. pmid:15513825
Hariharan M et al. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. 2004 Drug Dev Ind Pharm pmid:15285329
Jores K et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. 2004 J Control Release pmid:14980770
Gavini E et al. Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies. 2005 Pharm Dev Technol pmid:16370177
He J et al. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16400939
Souto EB and Müller RH SLN and NLC for topical delivery of ketoconazole. 2005 J Microencapsul pmid:16361193
Lombardi Borgia S et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. 2005 J Control Release pmid:16297487
Quintanar-Guerrero D et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. 2005 Eur J Pharm Sci pmid:16046105
Hu LD et al. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. 2005 Yao Xue Xue Bao pmid:15881775
Turkoglu M et al. Evaluation of hexagonal boron nitride as a new tablet lubricant. 2005 Pharm Dev Technol pmid:16176018
Jores K et al. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. 2005 Pharm. Res. pmid:16132349
Videira MA et al. Lymphatic uptake of lipid nanoparticles following endotracheal administration. 2006 J Microencapsul pmid:17390627
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Souto EB et al. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. 2006 J Microencapsul pmid:16854817
Hamdani J et al. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. 2006 Int J Pharm pmid:16824707
Li FQ et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. 2006 Int J Pharm pmid:16837152
Hamdani J et al. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. 2006 Int J Pharm pmid:16815656
Furlanetto S et al. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. 2006 Eur J Pharm Biopharm pmid:16154333
Castro GA et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. 2007 J Microencapsul pmid:17578730
Tursilli R et al. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. 2007 Eur J Pharm Biopharm pmid:17407809
Hou DZ et al. [Microstructure of novel solid lipid nanoparticle loaded triptolide]. 2007 Yao Xue Xue Bao pmid:17633214
Chen G et al. [Preliminary study on brain-targeted drug delivery via inner ear]. 2007 Yao Xue Xue Bao pmid:18229622
Ozyazici M et al. In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules. 2007 Pharm Dev Technol pmid:18161631
Thakkar H et al. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. 2007 Drugs R D pmid:17767393
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840
Brubach JB et al. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. 2007 Int J Pharm pmid:17207945
Ghimire M et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. 2007 Eur J Pharm Biopharm pmid:17498934
Montana G et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. 2007 Mar-Apr Bioconjug. Chem. pmid:17253655
UÄŸurlu T and TurkoÄŸlu M Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants. 2008 Int J Pharm pmid:18160235
Sengel-Türk CT et al. Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris. 2008 J Microencapsul pmid:18465309
Yuan H et al. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. 2008 Int J Pharm pmid:17714896
Dalpiaz A et al. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine. 2008 Int J Pharm pmid:18178347
Patel JK et al. In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design. 2009 Res Pharm Sci pmid:21589801
Lin YC et al. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. 2009 PLoS ONE pmid:19838303
Scalia S and Mezzena M Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability. 2009 AAPS PharmSciTech pmid:19381836
Scalia S and Mezzena M Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. 2009 Drug Dev Ind Pharm pmid:18785040
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Bhalekar MR et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. 2009 AAPS PharmSciTech pmid:19294517
Kuo YC and Chen HH Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. 2009 Int J Pharm pmid:18848610
Rao M et al. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices. 2009 AAPS PharmSciTech pmid:19333763
Gökçe EH et al. The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets. 2009 J Biomed Nanotechnol pmid:20055089
Barakat NS et al. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. 2009 Drug Deliv pmid:19555310
Abdelbary G and Fahmy RH Diazepam-loaded solid lipid nanoparticles: design and characterization. 2009 AAPS PharmSciTech pmid:19277870
Gohel M and Nagori SA Fabrication and evaluation of captopril modified-release oral formulation. 2009 Pharm Dev Technol pmid:19883258
Rahman Z et al. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. 2010 Eur J Pharm Biopharm pmid:20470882
Rajkumar M and Bhise S Carbamazepine-loaded porous microspheres for short-term sustained drug delivery. 2010 J Young Pharm pmid:21331184
Jeong SH and Park K Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets. 2010 Arch. Pharm. Res. pmid:20191352
UÄŸurlu T et al. Effects of lubricants on binary direct compression mixtures. 2010 Drug Discov Ther pmid:22491169
Durand L et al. Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. 2010 J Microencapsul pmid:21034364
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Hamza Yel-S and Aburahma MH Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. 2010 Drug Dev Ind Pharm pmid:19722915
Patel NV et al. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. 2010 Acta Pharm pmid:20228040
Stanisz B et al. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase. 2010 Jan-Feb Acta Pol Pharm pmid:20210086
Dhawan S et al. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. 2011 J. Pharm. Pharmacol. pmid:21749381
Gao Y et al. Lipid-polymer composite microspheres for colon-specific drug delivery prepared using an ultrasonic spray freeze-drying technique. 2011 J Microencapsul pmid:21767115
Fini A et al. Diclofenac salts, part 6: release from lipid microspheres. 2011 J Pharm Sci pmid:21523784
Kasongo KW et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. 2011 J Pharm Sci pmid:22020815
Alex A et al. Enhanced delivery of lopinavir to the CNS using Compritol-based solid lipid nanoparticles. 2011 Ther Deliv pmid:22833923
Yang R et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. 2011 Drug Dev Ind Pharm pmid:20578879
Jagdale S et al. Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion. 2011 J Young Pharm pmid:21897658
Setthacheewakul S et al. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). 2011 AAPS PharmSciTech pmid:21181511
González-Mira E et al. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. 2011 J Pharm Sci pmid:20575052
Blasi P et al. Lipid nanoparticles for brain targeting I. Formulation optimization. 2011 Int J Pharm pmid:21827844
Fini A et al. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization. 2011 J Pharm Sci pmid:20815082
Shah M et al. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. 2011 Drug Dev Ind Pharm pmid:21128704
Aji Alex MR et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. 2011 Eur J Pharm Sci pmid:20971188
Ghimire M et al. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. 2011 Eur J Pharm Biopharm pmid:20971189
Scalia S et al. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. 2011 Skin Pharmacol Physiol pmid:21336009
Pivette P et al. Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: analysis of drug and water diffusion processes with X-ray-based methods. 2012 J Control Release pmid:22138071
Wang G et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. 2012 Int J Nanomedicine pmid:22275840
Scalia S et al. Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. 2012 J Microencapsul pmid:22208706
Estella-Hermoso de Mendoza A et al. Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles. 2012 Nanomedicine (Lond) pmid:22630151
Spada G et al. Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery. 2012 Nanotechnology pmid:22323085
Roberts M et al. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. 2012 Drug Dev Ind Pharm pmid:22149472
Zhang H et al. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. 2012 Int J Nanomedicine pmid:22787390
Han F et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. 2012 Int J Pharm pmid:22989987
Taveira SF et al. Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin. 2012 J Biomed Nanotechnol pmid:22515073
Chen YC et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. 2012 Int J Nanomedicine pmid:22923986
Scalia S et al. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. 2013 Pharm Dev Technol pmid:22998063
Bose S and Michniak-Kohn B Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. 2013 Eur J Pharm Sci pmid:23246734